<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01952301</url>
  </required_header>
  <id_info>
    <org_study_id>13562-007</org_study_id>
    <nct_id>NCT01952301</nct_id>
  </id_info>
  <brief_title>Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation</brief_title>
  <official_title>A Randomized, Controlled Clinical Trial to Evaluate a Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Perio Health Professionals, PLLC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Perio Health Professionals, PLLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A split-mouth study comparing soft tissue augmentation results using free gingival graft
      (FGG) versus xenogeneic collagen matrix (CM) for the generation of keratinized tissue (KT)
      around teeth with insufficient (&lt; 2mm) KT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A single-blind, randomized, controlled, split-mouth study of 30 subjects with insufficient
      zones of KT (&lt; 2mm). The study utilized a within subject treatment comparison design to
      establish non-inferiority of the test (CM) versus control (FGG) therapy. The primary efficacy
      endpoint was KT width at 6-months. Secondary endpoints included traditional periodontal
      measures, such as clinical attachment, recession and bleeding on probing. Patient reported
      pain, discomfort and esthetic satisfaction were also recorded. Biopsies were obtained at
      6-months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Keratinized Tissue Width</measure>
    <time_frame>6 months</time_frame>
    <description>Change in Keratinized Tissue width</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Gingival Diseases</condition>
  <arm_group>
    <arm_group_label>xenogeneic collagen matrix</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Xenogeneic collagen matrix device placed on treatment wound bed site</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Free Gingival Graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional free gingival graft (autogenous graft device harvested from patient's palate) placed on treatment site wound bed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Xenogeneic Collagen Matrix</intervention_name>
    <description>A type I and III porcine collagen matrix, as cleared by FDA (K012423)</description>
    <arm_group_label>xenogeneic collagen matrix</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Free Gingival Graft</intervention_name>
    <description>Autogenous, full-thickness soft tissue graft harvested from patient's palate.</description>
    <arm_group_label>Free Gingival Graft</arm_group_label>
    <other_name>Free Autogenous Graft</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least two non-adjacent teeth in contralateral quadrants of the same jaw with &lt; 2mm
             of KT that requires soft tissue grafting (1-4 teeth may be treated). In case of
             adjacent teeth requiring grafting, only one tooth at each site will act as test or
             control tooth, but all teeth will get the same treatment). The number of teeth treated
             must be the same on the test and control sites.

               -  Root coverage is not desired at the time of grafting.

               -  Females of childbearing potential must have a documented negative urine pregnancy
                  test.

               -  Read, understood and signed an institutional review board (IRB) approved Informed
                  Consent Form (ICF).

               -  Able and willing to follow study procedures and instructions.

               -  Multi-rooted teeth may be treated but will not be included as study teeth

        Exclusion Criteria:

          -  Vestibule depth of less than 7mm from base of recession, and/or teeth with Miller
             Grade 2 or higher mobility.

               -  Any systemic conditions (i.e., diabetes mellitus, cancer, HIV, bone metabolic
                  diseases) that could compromise wound healing and/ or preclude periodontal
                  surgery; or who are currently receiving or have received within two months prior
                  to study entry, systemic corticosteroids, immunosuppressive agents, radiation
                  therapy, and/or chemotherapy which could compromise wound healing and preclude
                  periodontal surgery.

               -  Presence of acute infectious lesions in the areas intended for surgery.

               -  History of any tobacco use within the last six months.

               -  Taking intramuscular or intravenous bisphosphonates.

               -  Known hypersensitivity to collagen products, and/or allergy to iodine or
                  shellfish.

               -  Participating in other clinical studies involving therapeutic intervention
                  (either medical or dental).

               -  Previously undergone a gingival grafting procedure on the test or control teeth
                  or the teeth adjacent to the study site.

               -  Female subjects who are pregnant or lactating, or who intend to become pregnant
                  during the study duration following entrance into the study.

               -  Subjects, who in the opinion of the investigator, for any reason other than those
                  listed above, will not be able to complete the study per protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael K McGuire, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Perio Health Professionals</affiliation>
  </overall_official>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2013</study_first_submitted>
  <study_first_submitted_qc>September 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2013</study_first_posted>
  <results_first_submitted>January 28, 2014</results_first_submitted>
  <results_first_submitted_qc>April 16, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 15, 2014</results_first_posted>
  <last_update_submitted>May 24, 2014</last_update_submitted>
  <last_update_submitted_qc>May 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Perio Health Professionals, PLLC</investigator_affiliation>
    <investigator_full_name>Michael K McGuire</investigator_full_name>
    <investigator_title>Michael K McGuire DDS</investigator_title>
  </responsible_party>
  <keyword>Autologous; Collagen Matrix; Keratinized Tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingival Diseases</mesh_term>
    <mesh_term>Periodontal Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Our study sample was derived from the population of patients who presented at our practice between 11-3-2010 and 3-16-2011 and met predetermined selection criteria</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>XCM Versus FGG</title>
          <description>xenogeneic collagen matrix versus free gingival graft</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30">We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Xenogeneic Collagen Matrix Versus Free Gingival Graft</title>
          <description>free gingival graft versus a xenogeneic collagen matrix over an apically positioned flap used to generate keratinized tissue</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.9" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Keratinized Tissue Width</title>
        <description>Change in Keratinized Tissue width</description>
        <time_frame>6 months</time_frame>
        <population>Sample size was determined using 80% power fans assuming a paired t-test of non-inferiority with a non-inferiority margin of 1.0 mm, a within-subject standard deviation of 1.0 mm, and a one-sided alpha of 0.05, resulting in a sample size of 27. To account for potential loss-to-follow-up, 30 subjects were enrolled in the trial.</population>
        <group_list>
          <group group_id="O1">
            <title>Free Gingival Graft</title>
            <description>free gingival graft over an apically positioned flap used to generate keratinized tissue</description>
          </group>
          <group group_id="O2">
            <title>Xenogeneic Collagen Matrix</title>
            <description>xenogeneic collagen matrix over an apically positioned flap to generate keratinized tissue</description>
          </group>
        </group_list>
        <measure>
          <title>Keratinized Tissue Width</title>
          <description>Change in Keratinized Tissue width</description>
          <population>Sample size was determined using 80% power fans assuming a paired t-test of non-inferiority with a non-inferiority margin of 1.0 mm, a within-subject standard deviation of 1.0 mm, and a one-sided alpha of 0.05, resulting in a sample size of 27. To account for potential loss-to-follow-up, 30 subjects were enrolled in the trial.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.42" spread="0.64"/>
                    <measurement group_id="O2" value="2.92" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The primary hypothesis of the study evaluated whether CM was not inferior to Control in the generation of KT width from baseline to 6 months. A paired t-test was used to test for non-inferiority, using a one-sided significance level of 0.05 and a non-inferiority margin of 1.0 mm.</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Free Gingival Graft</title>
          <description>free gingival graft over an apically positioned flap used to generate keratinized tissue</description>
        </group>
        <group group_id="E2">
          <title>Xenogeneic Collagen Matrix</title>
          <description>xenogeneic collagen matrix over an apically positioned flap used to generate keratinized tissue</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Michael K. McGuire</name_or_title>
      <organization>Perio Health Professionals, PLLC</organization>
      <phone>713-783-5442</phone>
      <email>mkmperio@swbell.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

